| __timestamp | Blueprint Medicines Corporation | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 12402000000 |
| Thursday, January 1, 2015 | 48588000 | 17449000000 |
| Friday, January 1, 2016 | 81131000 | 17834000000 |
| Sunday, January 1, 2017 | 144687000 | 19551000000 |
| Monday, January 1, 2018 | 243621000 | 18265000000 |
| Tuesday, January 1, 2019 | 331450000 | 15607000000 |
| Wednesday, January 1, 2020 | 326860000 | 15410000000 |
| Friday, January 1, 2021 | 601033000 | 16541000000 |
| Saturday, January 1, 2022 | 477419000 | 17482000000 |
| Sunday, January 1, 2023 | 427720000 | 19381000000 |
| Monday, January 1, 2024 | 341433000 | 22873000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. This analysis compares the research and development (R&D) spending of two prominent companies: Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation, from 2014 to 2023.
Dr. Reddy's Laboratories, a global player, consistently invested heavily in R&D, with expenditures peaking at approximately $19.4 billion in 2023. This represents a steady increase of around 56% from their 2014 spending. In contrast, Blueprint Medicines, a relatively newer entrant, showed a remarkable growth trajectory, with R&D spending surging by over 1,200% from 2014 to 2023, reaching nearly $428 million.
While Dr. Reddy's maintains a robust R&D budget, Blueprint's rapid growth underscores its commitment to innovation. However, data for 2024 is missing, leaving room for speculation on future trends.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.